These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15766476)

  • 1. [A prospective study on trimetazidine effectiveness and tolerability in diabetic patients in association to the previous treatment of their coronary disease. DIETRIC study].
    Rodríguez Padial L; Maicas Bellido C; Velázquez Martín M; Gil Polo B
    Rev Clin Esp; 2005 Feb; 205(2):57-62. PubMed ID: 15766476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1.
    Szwed H; Sadowski Z; Pachocki R; Domzał-Bocheńska M; Szymczak K; Szydłowski Z; Paradowski A; Gajos G; Kałuza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
    Cardiovasc Drugs Ther; 1999 May; 13(3):217-22. PubMed ID: 10439884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes.
    Meiszterics Z; Kónyi A; Hild G; Sárszegi Z; Gaszner B
    J Comp Eff Res; 2017 Nov; 6(8):649-657. PubMed ID: 29148291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of trimetazidine in the treatment of diabetic microangiopathy in ischaemic heart disease].
    Fi Z; Kovács G; Szentes V
    Orv Hetil; 2015 May; 156(19):765-8. PubMed ID: 26039915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
    Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
    Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limited application of prevention measures in patients with diabetes mellitus type 2 and coronary artery disease in Spain. DIETRIC study].
    Rodríguez Padial L; Maicas Bellido C; Alcalá López J; Velázquez Martín M; Gil Polo B
    Rev Clin Esp; 2005 Jan; 205(1):14-8. PubMed ID: 15718012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefits of trimetazidine in patients with recurrent angina.
    Szwed H
    Coron Artery Dis; 2004 May; 15 Suppl 1():S17-21. PubMed ID: 15179124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-up.
    Xu X; Zhang W; Zhou Y; Zhao Y; Liu Y; Shi D; Zhou Z; Ma H; Wang Z; Yu M; Ma Q; Gao F; Shen H; Zhang J
    Clin Drug Investig; 2014 Apr; 34(4):251-8. PubMed ID: 24470342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV)
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):793-5. PubMed ID: 16266453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
    Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
    Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic management of coronary heart disease: adjunctive treatment with trimetazidine decreases QT dispersion in patients with a first acute myocardial infarction.
    Kountouris E; Pappa E; Pappas K; Dimitroula V; Karanikis P; Tzimas T; Siogas K
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):315-21. PubMed ID: 11800415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy: a 24-month study.
    El-Kady T; El-Sabban K; Gabaly M; Sabry A; Abdel-Hady S
    Am J Cardiovasc Drugs; 2005; 5(4):271-8. PubMed ID: 15984909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
    Shehata M
    Am J Cardiol; 2014 Aug; 114(3):389-94. PubMed ID: 24927970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of trimetazidine on exercise performance in patients with coronary artery ectasia.
    Dogan A; Ozaydin M; Gedikli O; Altinbas A; Ergene O
    Jpn Heart J; 2003 Jul; 44(4):463-70. PubMed ID: 12906028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease. The Turkish trimetazidine study (TTS).
    Koylan N; Bilge AK; Adalet K; Mercanoglu F; Büyüköztürk K;
    Acta Cardiol; 2004 Dec; 59(6):644-50. PubMed ID: 15636449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
    Rosano GM; Vitale C; Fragasso G
    Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.